These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 5159086)

  • 1. The metabolism of orally administered L-dopa in Parkinson patients.
    Cote LJ; Cohen G; Yahr MD
    Trans Am Neurol Assoc; 1971; 96():222-3. PubMed ID: 5159086
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism of L-dihydroxyphenylalanine by patients with Parkinson's disease.
    Tyce GM; Muenter MD; Owen CA
    Mayo Clin Proc; 1970 Sep; 45(9):645-56. PubMed ID: 5311767
    [No Abstract]   [Full Text] [Related]  

  • 3. L-dopa metabolism in man (with special reference to parkinsonism).
    Sandler M
    Sci Basis Med Annu Rev; 1972; ():161-73. PubMed ID: 4564341
    [No Abstract]   [Full Text] [Related]  

  • 4. Physiologic, biochemical, and pathological backgrounds of levodopa and possibilities for the future.
    Hornykiewicz OD
    Neurology; 1970 Dec; 20(12):1-5. PubMed ID: 5531292
    [No Abstract]   [Full Text] [Related]  

  • 5. L-Dopa, B 6 , and alpha-methyldopa hydrazine.
    Klawans HL; Ringel SP
    Confin Neurol; 1973; 35(3):186-92. PubMed ID: 4712885
    [No Abstract]   [Full Text] [Related]  

  • 6. Pyridoxine, DOPA, and Parkinsonism.
    Yahr MD; Duvoisin RC; Côté L; Cohen G
    Adv Biochem Psychopharmacol; 1972; 4():185-94. PubMed ID: 4555927
    [No Abstract]   [Full Text] [Related]  

  • 7. Absorption and metabolism of levodopa.
    Abrams WB; Coutinho CB; Leon AS; Spiegel HE
    JAMA; 1971 Dec; 218(13):1912-4. PubMed ID: 5171067
    [No Abstract]   [Full Text] [Related]  

  • 8. Brain dopamine and noradrenaline in 3 Parkinsonians deceased during L-dopa treatment.
    Buscaino GA; Jori A; Campanella G
    Acta Neurol (Napoli); 1972; 27(6):537-44. PubMed ID: 4651485
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biochemical bases for the treatment of Parkinson's syndrome with L-dopa].
    Pletscher A; Bartholini G; Gey KF; Jenni A
    Schweiz Med Wochenschr; 1970 May; 100(19):797-804. PubMed ID: 4924275
    [No Abstract]   [Full Text] [Related]  

  • 10. [L-dopa treatment and vitamin B 6 --clinical and chemical studies].
    Mawatari S; Izumi K; Kuroiwa Y
    Rinsho Shinkeigaku; 1972 Feb; 12(2):105-9. PubMed ID: 4674755
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic interactions of pyridoxine, levodopa, and carbidopa in Parkinson's disease.
    Mars H
    Trans Am Neurol Assoc; 1973; 98():241-5. PubMed ID: 4784941
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of Parkinson's disease with L-dopa].
    Guglielmi L; Vecchi L
    Clin Ter; 1970 May; 53(3):259-69. PubMed ID: 4917328
    [No Abstract]   [Full Text] [Related]  

  • 13. Catecholamine metabolism during oral administration of levodopa.
    Hinterberger H; Andrews CJ
    Arch Neurol; 1972 Mar; 26(3):245-52. PubMed ID: 5061285
    [No Abstract]   [Full Text] [Related]  

  • 14. The excretion of L-dopa metabolites at different hours of the day.
    Aguggini G; Meucci M; Reina G
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):749-57. PubMed ID: 4629113
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of vitamin B 6 on levodopa-induced changes in spinal fluid homovanillic acid.
    Klawans HL
    J Neurol Sci; 1971 Dec; 14(4):421-6. PubMed ID: 5125757
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma 3-0-methyldopa in L-dopa therapy of Parkinson's disease.
    Muenter MD; Sharpless NS; Tyce GM
    Mayo Clin Proc; 1972 Jun; 47(6):389-95. PubMed ID: 5041685
    [No Abstract]   [Full Text] [Related]  

  • 17. [Symposium: metabolism in neurological disorders. 1. Parkinsonism. 1-(2). Dopamin metabolism in urine and brain of patients with parkinsonism, with special reference to vitamin B 6 and L-DOPA-treatment].
    Kuzuya F; Wakita T; Kawahara H
    Nihon Naika Gakkai Zasshi; 1972 Sep; 61(9):1131-5. PubMed ID: 4674039
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biochemistry and treatment of Parkinson's disease].
    Barbeau A
    Laval Med; 1970 Sep; 41(7):902-5. PubMed ID: 5509487
    [No Abstract]   [Full Text] [Related]  

  • 19. L-dopa therapy in Parkinson's disease.
    Lipman IJ
    Va Med Mon (1918); 1971 May; 98(5):242-8. PubMed ID: 4931138
    [No Abstract]   [Full Text] [Related]  

  • 20. [L-Dopa in Parkinson's-syndrome. New therapeutic attack?].
    Brockmann AW
    Ther Ggw; 1970 Nov; 109(11):1590-3. PubMed ID: 5486128
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.